consensus of the helix assignment in the Protein Data Bank (PDB) of its active state structure and inactive structure, taken from the Orientations of Proteins in Membranes (OPM) database.(1) We then cropped out the TM regions and added missing atoms using tleap in AmberTools1.4.(2) To have meaningful comparisons of the energetics of structures sampled from inactive state crystal structure and from active state crystal structure, we minimized all these structures (TM regions only) using MPSim (3) with a convergence criterion of root mean square force (RMS force) = 0.25 kcal mol -1 Å -1 before proceeding to the conformational sampling steps.
Constructing the hybrid templates For Validation Method 2.1
We aligned the active state crystal structure to the inactive-state crystal structure using Visual Molecular Dynamics (VMD). (4) We considered only the backbone atoms in TM1-5 and TM7 in the alignment.
Then we replaced the TM6 in the inactive-state crystal structure with the TM6 in the active-state crystal structure.
For Validation Method 3.3
We obtained an active state candidate, denoted S1, from coarse SuperBiHelix sampling of the inactivestate crystal structure. Then we aligned the active-state crystal structure to S1 using VMD. We considered only the backbone atoms in the alignment. At last, we replaced the TM6 in S1 with the TM6 in the active-state crystal structure.
For application to hSSTR5
We obtained a homology model of the target protein using an inactive-state crystal structure as the template, and did coarse SuperBiHelix to obtain an active-state candidate T1. We also obtained the homology model of the target protein using an active-state crystal structure as the template, and name this model as T2. Then we aligned T2 to T1 using VMD. We considered only the backbone atoms in the alignment. At last, we replaced the TM6 in T1 with the TM6 in T2. The x,y coordinates of the hydrophobic center (HPC) of the hybrid template remain to be that of T1.
Energy scoring function in structure prediction
Whenever energy ranking was performed in structure prediction procedures, we used energy E CNti which is the average energy of four types of energy: a) the total energy of the charged protein (CTotal), b) the interhelical energy of the charged protein (CInterH), which neglects the intrahelical energy of each chain, c) the total energy (NTotal), and d) the interhelical energy (NInterH) of the neutralized protein.
Ligand docking

Scanning regions in protein for docking
The first step of GenDock(5, 6) is DarwinDock, which modifies the protein structure to replace the six types of hydrophobic residues by alanine, and then samples the complete set of poses for regions that could potentially bind a ligand. To do this sampling, the potential binding region is filled by SphGen with "spheres" having 2 Å overlaps with each other and the spheres classified into "boxes" of 10 Å sides. Boxes containing 75 or more spheres were kept. For docking purpose, we have discarded all spheres except for those that are in the extracellular half of the GPCR TMDs and are not potentially in contact with the membrane lipids (i.e. are in the interior of the GPCR helix bundle).
GenDock
For each ligand conformation and for the "spheres" selected in the previous step, we generated 200 000 poses without energy evaluation aiming at providing a complete set of poses. The poses were clustered into ~8000-9000 Voronoi families based on RMSD and the binding energy of the family head evaluated.
Then for the top 10% of families, we evaluated the energy for all children. Then we selected the top 50 based on each three energy scores: polar energy, hydrophobic energy, and total energy. Then for these 150, we dealanized (mutating alanine back to the original hydrophobic residues) and optimized the side chains using SCREAM. Then the protein-ligand complexes (poses) were subject to minimization for 50 steps.
Docking procedure of agonists to hSSTR5
For each ligand, we first did a conformational search using MacroModel 9.7(7) in Maestro 9. conformation was modified into F21 by adding back the -CH2-Ph group with each of the 9 possible conformations. The ligand conformations were then docked to each candidate protein structure using our standard docking strategy, GenDock,(5, 6) described above. The charge distribution used in docking was obtained by the Mulliken population analysis using B3LYP/6-311G** in Jaguar 7.6.(12) For each ligand and each docked protein, we collected 1000 lowest unified-cavity (UCav) energy complexes. Then for each ligand, we collected 15 lowest UCav energy complexes and matched ligands at different positions in these complexes into each of the protein conformations in these complexes. We did a simulated annealing on the resulting complexes' ligands and residues within 10 Å from the ligands. In the end, we minimized each of the complexes. The final complexes were scored by snap binding energy (SnapBE).
For each ligand, the lowest energy complex among all complexes with an active-state GPCR was selected as the final active-state pose, and the lowest energy complex among all complexes with an inactive-state GPCR was selected as the final inactive-state pose.
Molecular dynamics (MD) simulation
Preparing the crystal structures of hβ 2 AR and the G s protein for MD simulation
Starting from the active-state crystal structure coupled with the G s protein (PDB ID: 3SN6), we modeled the missing loops in the Gα domain of the G protein using the SWISS-MODEL server, (13) 
Loop building of hSSTR5
We modeled ICL1, ECL1 and ECL2 from mOPRM crystal structure (PDB ID: 4DKL)(14) using homology modeling. The remaining loops, ICL2, ICL3 and ECL3, were built with a Monte Carlo technique that grows geometrically allowed loop structures from the two fixed TM ends. Then we added the C-terminus of hSSTR5 up to the C-terminus of Helix8 (C320) by attaching Helix8 of the template after aligning their NPxxY motifs followed by mutating to hSSTR5. In addition, we added the Nterminus from residue 36 to 38. Minimization was then carried out on the final structure while keeping the TM domains (except the end residues) fixed until energy was converged.
Modeling Gα i
We used SWISS-MODEL (13) 2) For the agonist+GPCR+Gα s complex: Using VMD, the prepared agonist+GPCR+Gα s complex was inserted into a 120 Å × 130 Å lipid bilayer structure. This system was then placed into a water box with a total of ~39500 water molecules in the 15 Å and 60 Å thick space on the extracellular and intracellular sides of the lipid bilayer.
3) For Gα s alone: Using VMD, the prepared Gα s protein was placed into a rectangular water box with 10 Å thick of water padded on each of x-, y-, z-direction of the protein. There were a total of ~19400 water molecules.
4) For the agonist alone: Using VMD, the agonist taken from the prepared agonist+GPCR+Gα s complex was placed into a rectangular water box with 15 Å thick of water padded on each of x-, y-, z-direction of the molecule. There were a total of ~1700 water molecules.
For all the three cases above, in the end, Na + and Cl -ions were placed into the system using tleap for a physiological NaCl concentration (0.9% w/v) and a neutral system.
Building the lipid/water environment for hSSTR5
1) For ligand-bound GPCR: Using VMD, the final hSSTR5 structure with loops built was inserted into a 75 Å × 75 Å lipid bilayer structure. The system was then placed into a water box with a total of ~8300 water molecules in the 15 Å and 25 Å thick space on the extracellular and intracellular sides of the lipid bilayer.
2) For agonist+GPCR+Gα i complex: Using VMD, the agonist+GPCR+Gα i complex was inserted into a 120 Å × 100 Å lipid bilayer structure. The system was then placed into a water box with a total of ~29600 water molecules in the 15 Å and 60 Å thick space on the extracellular and intracellular sides of the lipid bilayer.
3) For Gα i alone: Using VMD, the modeled Gα i was placed into a rectangular water box with 10 Å thick of water padded on each of x-, y-, z-direction of the protein. There were a total of ~20800 water molecules.
4) For the agonist alone: Using VMD, the agonist taken from the agonist+GPCR+Gα i complex was placed into a rectangular water box with 15 Å thick of water padded on each of x-, y-, z-direction of the molecule. There were a total of 1855 water molecules.
For all the three cases above, in the end, Na + and Cl -ions were placed into the system with tleap for a physiological NaCl concentration and a neutral system.
MD simulation protocol
MD_Step1) With the ligand and TM regions of the receptor fixed, the loops and Helix8 of the receptor, lipids and water molecules in the system were minimized for 10000 steps using the conjugate gradient method. In the case of the agonist+GPCR+Gα complex, Gα is fixed in this step too. In the case of Gα alone in solvent, only Gα is fixed in this step, and the minimization was carried out for 5000 steps.
MD_Step2) With the ligand and TM regions of the receptor fixed, the loops and Helix8 of the receptor, the lipids and water molecules were equilibrated at 310 K and 1 atm for 1 ns using the NPT ensemble.
This allowed the water molecules to defuse into the ligand-protein system filling any artificial voids in the simulation system. In the case of the agonist+GPCR+Gα complex, Gα is fixed in this step too. In the case of Gα alone in solvent, only Gα is fixed in this step, and the equilibration was for 1.5 ns.
MD_Step3) The whole system was then minimized for 10000 steps using the conjugate gradient method.
In the case of Gα alone in solvent, the minimization was carried out for 5000 steps.
MD_Step4) The whole system was heated from 0 K to 310 K in hundreds of ps and then equilibrated using the NPT ensemble for a total of 51 ns MD simulation.
For the simulation of apo-GPCR+Gα, we took the last frame of agonist+GPCR+Gα complex from the above procedure, removed the ligand from the system, adjusted the number of Na + or Cl -ions to make the system neutral again if the ligand was charged, and repeated the above MD protocol MD_Step1) to MD_Step4) with the all parts of the proteins fixed in MD_Step1). (23) antagonist-bound -6.14 -TABLE S2 Summary of structural features and energies of hβ 2 AR and hM2 optimal structures generated from different methods. The "Structure Identifier" corresponds to the numbers in Fig. 1 . Each RMSD value is between the backbone atoms of the resulting optimal structure of the particular method and the backbone atoms of the active-state crystal structure preprocessed according to Supporting Materials and Methods. For hM2, the second best choice of 3.2 is also listed for comparison. Unlike hβ 2 AR for which the inactive state is 73.8 kcal mol -1 more stable than the active state, this value for hM2 is only 3.7 kcal mol -1 . Therefore, the number of 7-helix bundles built from SuperBiHelix results is increased to 2500 to capture more candidates in the active-like regime. (For hβ 2 AR, building 1000 or 2500 bundles has the same the final results shown in this table.) While hM2's lowest-energy structure from AfromI_Fine that satisfies the active-like R 36 criterion (upper row of 3.2 in the table) has a much larger RMSD than Structure 3.1 to the active-state crystal structure, the second-lowest-energy structure (lower row of 3.2 in the table) has an improved RMSD comparing to 3.1. This suggests selecting a small number of diverse structures from the potential energy well may help in active-state structure prediction as well. FIGURE S1 Schematic view of ActiveGEnSeMBLE. R 36 is the minimal approach distance between the backbone atoms of the intracellular ends of TM3 and TM6, defined in the Materials and Methods section. R 36 (i) is that of the inactive structure. R is a distance, usually chosen around 4 Å. Among all cases involved in this paper, the optional step was only carried out for hSSTR5 structure prediction, and it was found to be unnecessary as the final selected structures are the same as those without this step carried out. The sampling space of BiHelix is Δη from 0 to 360° in 30° increments. If not noted otherwise, the sampling space of Coarse SuperBiHelix is Δθ: 0, ±15°; Δφ: 0, ±45°, ±90°; Δη: 0, ±30°, selected angles from BiHelix/CombiHelix, starting with the best from BiHelix/CombiHelix. The sampling space of Fine SuperBiHelix is Δθ: 0, ±15°; Δφ: 0, ±15°, ±30°; Δη: 0, ±30°. The active state template for TM6 is chosen to be hβ 2 AR (PDB ID: 3SN6) in this study because it is by far the only GPCR co-crystalized with a full G protein heterotrimer. (24) and bRho (pink) in its Gα t -C-terminus-coupled crystal structure (PDB ID: 3PQR)(17) to the predicted hβ 2 AR structure without changing the relative orientation within each crystal structure. We find the minimum energy structure of hβ 2 AR in the R 36 ≈ 12.4 Å well clashes with Gα s but not with arrestin. It is hard to determine by speculation whether it distinguishes arrestin with the G i protein because the C-terminus helix of Gα t subunit (red) cocrystalized with the active-state bRho is similar in position with the part of arrestin inside the GPCR.
II. Supporting Tables and Figures
(Therefore, similar analysis was not carried out on hM2 which couples with the G i protein instead of G s in vivo.) This structure is from the ensemble of structures generated using Method 3.2 which uses the inactive-state TM shapes for all TMs. It is characterized by Δθ = 0 for all helices; Δφ = -15°, 0, 0, 15°, 0, -30°, 15°; Δη = 0, 0, 0, 0, 0, -30°, 0 with the values ordered from TM1 to TM7. It has E CNti = -114.1 kcal mol -1 . The coordinates of this predicted structure are included in the Supporting Material as a separate file in the PDB format. FIGURE S3 Potential energy profile from sampling hM2 conformations. The black curve is an illustration showing how our sampling results can qualitatively be translated into a potential energy curve using R 36 as the x-axis and does not quantitatively represent any real data. Results of the coarse sampling starting from the inactive-state crystal structure are in blue circles. Starting from Structure 3.1, results of methods that generated Structures 3.2 and 3.3 are shown in red crosses and red squares respectively. Starting from the Structure 4.1, results of the fine sampling that generated Structure 4.2 are in green dots. Every blue arrow points from a starting structure towards the optimal structure from the corresponding sampling method. 2.50 of hSSTR5 is formed during the MD simulation of the agonist+ActiveConf2+Gα i complex. In addition, there is π-π stacking between L-817,818 and W261 6.48 in the agonist+ActiveConf2+Gα i complex. There is no water molecule within 10 Å of the side chain of D86 2.50 . c) The presence of the transmission switch: W261 6.48 and F257 6.44 are oriented towards P213 5.50 in ActiveConf2 (right panel) but not in InactiveConf2 (left panel) partly due to the rotation of TM6. The secondary structure in agonist+InactiveConf2 is shown in grey, and that in agonist+ActiveConf2+Gα i is shown in orange. Carbons in the residues on hSSTR5 are shown in cyan. The agonist carbon atoms are shown in purple. FIGURE S16 Distance between the N atom in an amine group of L-817,818 (the same amine group in Fig. S15 ) and a carboxylic acid oxygen atom in D86 2.50 of hSSTR5 along the trajectory of MD simulation of the agonist+InactiveConf2 complex. 
